MENU
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Climb Bio (CLYM) Earnings Date & Reports
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases... Show more
A.I. Advisor
published Earnings
CLYM is expected to report earnings to rise 5.56% to -18 cents per share on November 05
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.03
Q1'26
Beat
by $0.09
Q4'25
Missed
by $0.07
Q3'25
Missed
by $0.04
The last earnings report on August 06 showed earnings per share of -18 cents, beating the estimate of -20 cents. With 317.01K shares outstanding, the current market capitalization sits at 605.38M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
20 William Street
Phone
+1 866 857-2596
Employees
29
Web
https://www.climbbio.com